Results 1 to 10 of about 101,476 (335)

Cutaneous leishmaniasis mimicking cutaneous lymphoma [PDF]

IDCases, 2019
Cutaneous leishmaniasis (CL) is caused by protozoa of Leishmania genus that are transmitted to humans through the bite of sand flies (Lutzomyia and Phlebotomus). The infection is classically manifested as multiple or single ulcers affecting cutaneous and/
Carla Andréa Avelar Pires, Nathalia Gabay Pereira, Amanda Gabay Moreira, Julie Marie Costa Sena, Caio César Chaves Costa, Thalita dos Santos Bastos, Fernanda do Nascimento Rodrigues, Evelyn de Paiva Faustino, Jéssica Rayanne Corrêa da Silva, Maria Amélia Lopes dos Santos   +9 more
doaj   +5 more sources

Epidemiology of cutaneous lymphoma. [PDF]

Br J Dermatol, 2021
Linked Article: Dobos et al. Br J Dermatol 2021; 184:1059–1067.
Vermeer M.
europepmc   +4 more sources

Care and treatment for primary cutaneous lymphoma-associated ulcers: Two case reports [PDF]

SAGE Open Medical Case Reports
Primary cutaneous lymphoma is a heterogeneous group of cutaneous lymphocytic primary tumors belonging to the extranodal category of non-Hodgkin lymphoma.
Min Wei, Jun Wei, Jian Li, Ruyue Li, Jing Liu   +4 more
doaj   +2 more sources

What Does the Future Hold for Biomarkers of Response to Extracorporeal Photopheresis for Mycosis Fungoides and Sézary Syndrome?

Cells, 2023
Extracorporeal photopheresis (ECP) is an FDA-approved immunotherapy for cutaneous T-cell lymphoma, which can provide a complete response in some patients. However, it is still being determined who will respond well, and predictive biomarkers are urgently
Oleg E. Akilov
doaj   +1 more source

Targeting the CD47-SIRPα Axis: Present Therapies and the Future for Cutaneous T-cell Lymphoma

Cells, 2022
The loss of CD47 on aging cells serves as a signal to macrophages to eliminate the target. Therefore, CD47 is a “do-not-eat-me” sign preventing macrophagal phagocytosis via interaction with its ligand SIRPα. Malignant lymphocytes of mycosis fungoides and
Amy Xiao, Oleg E. Akilov
doaj   +1 more source

Cutaneous Involvement of Extranodal NK/T Cell Lymphoma, Nasal Type, a Clinical and Histopathological Mimicker of Various Skin Diseases

Dermatopathology, 2022
Background: Extranodal NK/T cell lymphoma, nasal type (ENK/T) with cutaneous involvement has various histopathological findings and diverse clinical manifestations.
Preeyawat Ngamdamrongkiat, Sanya Sukpanichnant, Manasmon Chairatchaneeboon, Archrob Khuhapinant, Panitta Sitthinamsuwan   +4 more
doaj   +1 more source

Reliable blood cancer cells' telomere length evaluation by qPCR

Cancer Medicine, 2020
Background Telomere shortening is linked to a range of different human diseases, hence reliable measurement methods are needed to uncover such associations.
Joana Ropio, Alain Chebly, Jacky Ferrer, Martina Prochazkova‐Carlotti, Yamina Idrissi, Lamia Azzi‐Martin, David Cappellen, Anne Pham‐Ledard, Paula Soares, Jean‐Philippe Merlio, Edith Chevret   +10 more
doaj   +1 more source

Investigating a fast-growing nodule on the face: A case of primary cutaneous marginal zone lymphoma [PDF]

Journal of Krishna Institute of Medical Sciences University, 2022
Primary cutaneous B-cell lymphomas are non-Hodgkin lymphomas that present in the skin without evidence of extracutaneous involvement at diagnosis. There are three types of primary cutaneous B-cell lymphomas: primary cutaneous marginal zone lymphoma ...
N. Ashok Kumar, Sane Roja Renuka, C. Geo Danny , Richa Jotwani   +3 more
doaj  

Primary Cutaneous B-Cell Lymphoma: An Update on Pathologic and Molecular Features

Hemato, 2022
Primary cutaneous B-cell lymphomas (PCBCLs) account for 25% of all primary cutaneous lymphomas. Three major types are currently recognized by the WHO classification: primary cutaneous marginal zone B-cell lymphoma (PCMZL), primary cutaneous follicle ...
Marco Lucioni, Sara Fraticelli, Giuseppe Neri, Monica Feltri, Giuseppina Ferrario, Roberta Riboni, Marco Paulli   +6 more
doaj   +1 more source

Long-term Therapeutic Success of Intravenous Rituximab in 26 Patients with Indolent Primary Cutaneous B-cell Lymphoma

Acta Dermato-Venereologica, 2021
Systemic monotherapy with rituximab is a well-known treatment approach for primary cutaneous follicle centre lymphoma and primary cutaneous marginal zone lymphoma. Both have excellent prognosis despite high relapse rates.
Stefanie Porkert, Pamela Mai, Constanze Jonak, Felix Weihsengruber, Klemens Rappersberger, Wolfgang Bauer, Ingrid Simonitsch-Klupp, Markus Raderer, Julia Valencak   +8 more
doaj   +1 more source